Skip to main content
Top
Published in: BMC Neurology 1/2018

Open Access 01-12-2018 | Case report

Castleman disease of the hyaline vascular variant transforming to POEMS syndrome as endpoint: a case report

Authors: Yijun Ge, Qian Da, Ying Dai

Published in: BMC Neurology | Issue 1/2018

Login to get access

Abstract

Background

POEMS syndrome is a rare neoplastic syndrome reflected by plasma cell disorder. It is composed by polyneuropathy, organomegaly, endocrinopathy, monoclonal protein, and skin changes. It is also reported to associate with Castleman disease. The early identification and treatment are pivotal to reduce the morbidity and mortality.

Case presentation

Here we report a 66-year-old man with treated Castleman disease developing with sequential presence of endocrinopathy polyneuropathy, skin changes, organomegaly and extravascular volume overload within 18 years, which was finally confirmed as POEMS syndrome by positive monoclonal protein. He was thereafter successfully treated with prednisone and azathioprine as primary therapy and thalidomide as maintenance therapy.

Conclusion

The diagnosis of POEMS is based on a cluster of disorder involved in varied organs. We report a rare case that triggers the need to consider POEMS syndrome diagnosis for patients carrying Castleman disease and polyneuropathy.
Literature
1.
go back to reference Li J, Zhou DB. New advances in the diagnosis and treatment of POEMS syndrome. Br J Haematol. 2013;161:303–15.CrossRef Li J, Zhou DB. New advances in the diagnosis and treatment of POEMS syndrome. Br J Haematol. 2013;161:303–15.CrossRef
2.
go back to reference Dispenzieri A, Kyle RA, Lacy MQ, Rajkumar SV, Therneau TM, Larson DR, et al. POEMS syndrome: definitions and long-term outcome. Blood. 2003;101:2496–506.CrossRef Dispenzieri A, Kyle RA, Lacy MQ, Rajkumar SV, Therneau TM, Larson DR, et al. POEMS syndrome: definitions and long-term outcome. Blood. 2003;101:2496–506.CrossRef
3.
go back to reference Dispenzieri A. POEMS syndrome: update on diagnosis, risk-stratification, and management. Am J Hematol. 2015;90:951–62.CrossRef Dispenzieri A. POEMS syndrome: update on diagnosis, risk-stratification, and management. Am J Hematol. 2015;90:951–62.CrossRef
4.
go back to reference Nakanishi T, Sobue I, Toyokura Y, Nishitani H, Kuroiwa Y, Satoyoshi E, et al. The crow-Fukase syndrome: a study of 102 cases in Japan. Neurology. 1984;34:712–20.CrossRef Nakanishi T, Sobue I, Toyokura Y, Nishitani H, Kuroiwa Y, Satoyoshi E, et al. The crow-Fukase syndrome: a study of 102 cases in Japan. Neurology. 1984;34:712–20.CrossRef
5.
go back to reference Li J, Zhou DB, Huang Z, Jiao L, Duan MH, Zhang W, et al. Clinical characteristics and long-term outcome of patients with POEMS syndrome in China. Ann Hematol. 2011;90:819–26.CrossRef Li J, Zhou DB, Huang Z, Jiao L, Duan MH, Zhang W, et al. Clinical characteristics and long-term outcome of patients with POEMS syndrome in China. Ann Hematol. 2011;90:819–26.CrossRef
6.
go back to reference Afridi F, Otoya J, Bunting SF, Chaaya G. An unfortunate polyneuropathy, Organomegaly, Endocrinopathy, monoclonal Gammopathy, and skin change (POEMS). Cureus. 2017;9:e1086.PubMedPubMedCentral Afridi F, Otoya J, Bunting SF, Chaaya G. An unfortunate polyneuropathy, Organomegaly, Endocrinopathy, monoclonal Gammopathy, and skin change (POEMS). Cureus. 2017;9:e1086.PubMedPubMedCentral
7.
go back to reference Scarlato M, Previtali SC, Carpo M, Pareyson D, Briani C, Del Bo R, et al. Polyneuropathy in POEMS syndrome: role of angiogenic factors in the pathogenesis. Brain. 2005;128:1911–20.CrossRef Scarlato M, Previtali SC, Carpo M, Pareyson D, Briani C, Del Bo R, et al. Polyneuropathy in POEMS syndrome: role of angiogenic factors in the pathogenesis. Brain. 2005;128:1911–20.CrossRef
8.
go back to reference Watanabe O, Maruyama I, Arimura K, Kitajima I, Arimura H, Hanatani M, et al. Overproduction of vascular endothelial growth factor/vascular permeability factor is causative in crow-Fukase (POEMS) syndrome. Muscle Nerve. 1998;21:1390–7.CrossRef Watanabe O, Maruyama I, Arimura K, Kitajima I, Arimura H, Hanatani M, et al. Overproduction of vascular endothelial growth factor/vascular permeability factor is causative in crow-Fukase (POEMS) syndrome. Muscle Nerve. 1998;21:1390–7.CrossRef
9.
go back to reference D'Souza A, Hayman SR, Buadi F, Mauermann M, Lacy MQ, Gertz MA, et al. The utility of plasma vascular endothelial growth factor levels in the diagnosis and follow-up of patients with POEMS syndrome. Blood. 2011;118:4663–5.CrossRef D'Souza A, Hayman SR, Buadi F, Mauermann M, Lacy MQ, Gertz MA, et al. The utility of plasma vascular endothelial growth factor levels in the diagnosis and follow-up of patients with POEMS syndrome. Blood. 2011;118:4663–5.CrossRef
Metadata
Title
Castleman disease of the hyaline vascular variant transforming to POEMS syndrome as endpoint: a case report
Authors
Yijun Ge
Qian Da
Ying Dai
Publication date
01-12-2018
Publisher
BioMed Central
Published in
BMC Neurology / Issue 1/2018
Electronic ISSN: 1471-2377
DOI
https://doi.org/10.1186/s12883-018-1172-7

Other articles of this Issue 1/2018

BMC Neurology 1/2018 Go to the issue